ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 97 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,491 | -81.9% | 14,269 | -71.7% | 0.00% | -80.0% |
| Q2 2023 | $378,737 | +93.7% | 50,431 | +16.6% | 0.01% | +100.0% |
| Q1 2023 | $195,576 | +3.6% | 43,269 | +158.3% | 0.01% | 0.0% |
| Q4 2022 | $188,761 | +4.9% | 16,749 | -24.6% | 0.01% | -37.5% |
| Q2 2022 | $180,000 | -70.8% | 22,211 | -22.6% | 0.01% | -78.9% |
| Q4 2021 | $616,000 | +145.4% | 28,678 | +744.0% | 0.04% | +90.0% |
| Q3 2021 | $251,000 | +8.2% | 3,398 | -19.9% | 0.02% | 0.0% |
| Q2 2021 | $232,000 | – | 4,241 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $92,828,000 | 21.48% |
| Vivo Capital, LLC | 4,220,048 | $40,386,000 | 4.46% |
| Logos Global Management LP | 2,971,352 | $28,436,000 | 3.50% |
| Samsara BioCapital, LLC | 262,786 | $2,515,000 | 0.59% |
| Orbimed Advisors | 2,871,000 | $27,475,000 | 0.51% |
| Cormorant Asset Management, LP | 712,079 | $6,815,000 | 0.48% |
| Pier Capital, LLC | 272,617 | $2,609,000 | 0.45% |
| Redmile Group, LLC | 752,097 | $7,198,000 | 0.28% |
| Nan Fung Group Holdings Ltd | 41,950 | $401,000 | 0.26% |
| Artal Group S.A. | 500,000 | $4,785,000 | 0.20% |